Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001708599-25-000038
Filing Date
2025-04-10
Accepted
2025-04-10 16:03:12
Documents
1
Period of Report
2025-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1744315385.html 4  
1 FORM 4 wk-form4_1744315385.xml 4 3919
  Complete submission text file 0001708599-25-000038.txt   5502
Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 25828317

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)